Month 1 Researchers continued monitoring appetite, weight, and tolerability
A total of 569 patients out of 8803 (6.5%) receiving semaglutide experienced this outcome as compared to 701 patients out of 8801 (8.0%) receiving placebo (between-group difference of 1.5%)
At Hillcroft Physicians, our semaglutide program is designed to support you every step of the way
Oral tablets , like Rybelsus or the newly-approved Wegovy tablet, are great for those who prefer a pill over an injection
Some patients benefit from temporary prokinetic medications (like metoclopramide or domperidone) prescribed by their provider to restore stomach motility while remaining on tirzepatide at a reduced dose
Our providers will take a comprehensive look at your medical history, current medications, body mass index (BMI), and overall health to determine if Ozempic is a good fit for your unique needs